RxDoctor Payments Data

Sean Park

Radiation Oncology · Rochester, MNNPI 1447464078

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 49.5% of the total. Reporting peaked in 2023 at $2,162 and has fallen 88.6% since, to $247 in 2025. Among radiation oncology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,043in general payments, 2019–2025

Across 13 payments — averaging $311.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$2K
  • Novocure Inc.$1K
  • Teleflex LLC$194
  • Johnson & Johnson$103
  • AstraZeneca$68
  • Ion Beam Applications S.A.$66
  • plus $112 from 2 others

What the payments were for

  • Consulting fees$1,35033%
  • Speaking & faculty fees$2,00049%
  • Food & beverage$69317%

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,043 in reported general payments places this provider in the 90th percentile of 128 radiation oncology providers in Minnesota.

See all radiation oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$147,435
Medicare patients
164
Services billed
1,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →